Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Analytical variables

Figure 4.43. Yields determined for a large number of batches of four bulk chemicals and four drug substances. During the early synthesis steps the yields are variable 10 batches run during one campain of the first compound clump near 95%. The result at about 107% is due to analytical variability and/or calibration bias. The final synthesis step of a drug compound, for which the aggregate value of a kilogram of material is much higher, has been trimmed for maximal yield. Figure 4.43. Yields determined for a large number of batches of four bulk chemicals and four drug substances. During the early synthesis steps the yields are variable 10 batches run during one campain of the first compound clump near 95%. The result at about 107% is due to analytical variability and/or calibration bias. The final synthesis step of a drug compound, for which the aggregate value of a kilogram of material is much higher, has been trimmed for maximal yield.
Figure 4.52. Coefficients of variation that reflect both tablet to tablet and analytical variability. For formulation B, particularly strengths 2 and 3, the drop in CV with higher cumulative release (a - b) is marked, cf. Fig, 4.50. When the dissolution rate is high, individual differences dominate, while towards the end analytical uncertainty is all that remains. The very low CVs obtained with strength 3 of formulation A ( 0.7-0.8%, data offset by +10% for clarity) are indicative of the analytical uncertainty. Because content uniformity is harder to achieve the lower the drug-to-excipient ratio, this pattern is not unexpected. Figure 4.52. Coefficients of variation that reflect both tablet to tablet and analytical variability. For formulation B, particularly strengths 2 and 3, the drop in CV with higher cumulative release (a - b) is marked, cf. Fig, 4.50. When the dissolution rate is high, individual differences dominate, while towards the end analytical uncertainty is all that remains. The very low CVs obtained with strength 3 of formulation A ( 0.7-0.8%, data offset by +10% for clarity) are indicative of the analytical uncertainty. Because content uniformity is harder to achieve the lower the drug-to-excipient ratio, this pattern is not unexpected.
After a brief period of use, the graphite tubes and rods that are commonly employed In electrothermal atomizers begin to deteriorate, and their electrical characteristics become subject to drift (7,9,47). This is one of the most troublesome sources of analytical variability. Maessen et al (47) demonstrated that the properties of graphite (e.g. porosity ancl conductivity)... [Pg.251]

It is recognized that carotenoid analysis is inherently difficult and errors can be introduced in aU steps. Thus continued efforts focusing on analytical refinements are justified so that analytical variability is not mistaken for natural variation of samples. [Pg.472]

Horwitz claims that irrespective of the complexity found within various analytical methods the limits of analytical variability can be expressed or summarized by plotting the calculated mean coefficient of variation (CV), expressed as powers of two [ordinate], against the analyte level measured, expressed as powers of 10 [abscissa]. In an analysis of 150 independent Association of Official Analytical Chemists (AOAC) interlaboratory collaborative studies covering numerous methods, such as chromatography, atomic absorption, molecular absorption spectroscopy, spectrophotometry, and bioassay, it appears that the relationship describing the CV of an analytical method and the absolute analyte concentration is independent of the analyte type or the method used for detection. [Pg.483]

Each cycle results in a doubling of the number of strands of DNA found at the previous step. After 20 PCR cycles, the two original strands of DNA will have been amplified a millionfold (220 = 1 million), while after 30 cycles the amplification will be a billionfold. However, after 30 PCR cycles the amplification reaction reaches a plateau, primarily because of the excess of DNA synthesized (substrate excess), competition by nonspecific products, and reassociation of product. Figure 3 is a diagrammatic representation of PCR. A few selected analytical variables affecting PCR need to be considered. First, the reannealing temperature is critical to the specificity of the amplification. Low temperatures of between... [Pg.14]

To learn that the changes in concentration caused by current flow will follow Faraday s laws, so the analytical variable during measurement is current, where / oc Canaiyte-... [Pg.131]

Accuracy is an expensive commodity. It involves exhaustive testing of the candidate method. Thorough delineation and careful control of analytical variables is essential to accurate analyses. [Pg.254]

Espina V, Mueller C (2012) Reduction of pre-analytical variability in specimen procurement for molecular profiling. Methods Mol Biol 823 49-57... [Pg.213]

The second data treatment was based on canonical correlation (BMDP6M) which finds combinations of two sets of data which show high correlation, i.e. what combination of analytical variables (A1-A2) shows a high correlation with another combination of sensory variables (S1-S2) (Table III). Canonical factor 1 (A1 and SI, R =99%) contained information relating bright vs hurley vs oriental as can be seen by high loadings on those... [Pg.126]

Table 4.3. Physical Observation and Analytical Variability at 15 min of Dissolution... Table 4.3. Physical Observation and Analytical Variability at 15 min of Dissolution...
Included is a graph (Figure 5) from an article by William Horwitz which relates analytical precision to concentration. It shows that the analytical variability increases as the concentration decreases. The Horwitz data were generated fran collaborative studies where methodology was exactly defined. The data should be... [Pg.87]

Furthermore, it should be hinted that FA can also be used to select analytical variables for optimization of laboratory efforts in future groundwater or river water studies [ANDRADE et al., 1994],... [Pg.296]

A well-designed stability program meets all regulatory requirements and attains its objectives with minimal expenditure of resources. It provides all necessary data in a form that can be easily interpreted and evaluated, and distinguishes between analytical variability and instability. It specifies a testing frequency, which will provide early detection of instability and support the desired expiration-dating period. [Pg.213]

Pre-Analytical Variables Tissue Preservation, Transportation, Fixation and Tissue Processing... [Pg.84]

Analytical Variables - Antigen Retrieval, Antibodies, Detection Systems and Controls... [Pg.88]

Unlike the pre-analytical factors, analytical factors are more readily controlled within the individual laboratory. Analytical variables that are associated with the demonstration of the antigen include antibody specificity and sensitivity, dilution, detection system, and antigen retrieval. [Pg.88]

The most appropriate control for any immunostain would be an internal control because it would have been subjected to identical pre-analytical and analytical variables as the test tissue. However, such controls are invariably non-lesional or benign cells that express the antigen of interest at levels different to the tumor cells and are thus not ideal controls. Nonetheless, they are currently the best controls available. [Pg.98]

The alternative, an external control of similar tumor tissue known to express the antigen of interest, would have been subjected to an entirely different set of pre-analytical variables. It is inappropriate to use benign tissue as external controls when examining tumor cells. [Pg.99]

Another method of validation is the use of standard samples from an approved source but such sources and tissue are not currently available. The use of consensus positive and negative tissue in the form of tissue microarrays is a possible substitute (Fitzgibbons et al, 2006). Alternatively, tissue samples from cases accessioned by your own laboratory known to harbor the target protein by non-IHC means can be used, but in all these situations it has to be remembered that there is no fixation or processing standard so that agreement between laboratories and between samples is subject to pre-analytical variables discussed previously. Clearly the ideal validation procedure would be against patient outcome but this is a costly exercise and often not practical as they require appropriate numbers of patients and a prospective study. [Pg.101]

In the previous section, the duplicate-replicate control data set was used to give graphical representation of sampling and analytical variability. A statistical procedure referred to as analysis of variance (ANOVA) analysis can be done on the same data set to give a more quantitative statement on variability. Sinclair (1983) describes this method that compares variations that arise from different identifiable sources,... [Pg.106]

Because X-ray powder diffraction deals with solid samples, the analytical variables are different from those associated with the analysis of liquid or solution samples. Principle among these are particle size effects, uniform sample surface, crystallinity and X-ray absorption. Although particle size and a non-uniform sample surface are serious problems, their... [Pg.44]


See other pages where Analytical variables is mentioned: [Pg.228]    [Pg.84]    [Pg.86]    [Pg.56]    [Pg.225]    [Pg.153]    [Pg.36]    [Pg.53]    [Pg.71]    [Pg.200]    [Pg.72]    [Pg.214]    [Pg.24]    [Pg.497]    [Pg.380]    [Pg.391]    [Pg.413]    [Pg.14]    [Pg.81]    [Pg.82]    [Pg.95]    [Pg.99]    [Pg.102]    [Pg.106]    [Pg.111]    [Pg.686]    [Pg.686]    [Pg.16]    [Pg.41]   


SEARCH



© 2024 chempedia.info